Therefore, in this section we discuss some challenging clinical features, in terms of frequency or severity, in the management of SLE-related CNS involvement ... joint (e.g., pain syndrome ...

Systemic lupus erythematosus (SLE) is the most common type of lupus, a chronic autoimmune disease. Symptoms include fatigue, joint pain, and rashes across your nose and cheeks. While there’s no ...

Mean hospital length of stay was longer for SLE with vs without lung involvement. This article is part of MPR’s coverage of the CHEST Virtual 2020 meeting. Lung involvement during ...

Disease phenotypes such as nervous system involvement and joint involvement were not examined. The metabolic biomarkers for SLE warrant validation in a larger cohort of patients with the disorder.

SLE is a heterogeneous disease ... as well as their disease type, severity of organ involvement, and any comorbidities. Early diagnosis, regular screening for new organ manifestations, prompt ...

SLE is a heterogeneous disease ... as well as their disease type, severity of organ involvement, and any comorbidities. Early diagnosis, regular screening for new organ manifestations, prompt ...

ADI-001 is an allogeneic gamma delta CAR T-cell therapy that targets the B-cell antigen CD20. The Food and Drug Administration (FDA) has granted Fast Track designation to ADI-001 for the treatment ...

New data show litifilimab outperformed placebo in patients with active arthritis and skin manifestations due to systemic lupus erythematosus (SLE). Antibody binding of blood dendritic cell antigen ...

ADI-001 was granted Fast Track Designation by the FDA for the treatment of relapsed/refractory class III or class IV lupus nephritis (LN), and SLE with extrarenal involvement. The Company is ...

They may also recommend an X-ray or other tests to check for organ involvement. Around one-third of people with SLE have inflammation that affects their kidneys, resulting in a condition called ...